← Eichor
Study identifier: NCT06127316 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effects of Heel Distraction Height on Foot Loading With Carbon Fiber Custom Dynamic Orthoses

Condition: Traumatic Lower Limb Injury  ·  Sponsor: University of Iowa

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Carbon fiber custom dynamic orthoses (CDOs) and unloading ankle foot orthoses (AFOs) have shown varying levels of success in reducing forces acting on different regions of the bottom of the foot during gait. CDOs and unloading AFOs have shown differing offloading capabilities across different regions of the foots (hindfoot, midfoot, forefoot) which may be related to a distinct difference between CDOs and unloading AFOs: CDOs do not suspend, or distract, the foot away from the footplate. The purpose of this study is to determine the effects of CDOs and heel distraction height (the distance between the heel and the footplate) on limb loading and motion during gait as well as patient reported pain, and comfort.

This description comes directly from the study's public registry record.

Talk to the study team

Jason M Wilken, PT, PhD  ·  3193356857  ·  jason-wilken@uiowa.edu

Kirsten M Anderson, PhD  ·  3193530431  ·  kirsten-m-anderson@uiowa.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of IowaIowa City, Iowa, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06127316